2. Academic Validation
  3. OSBPL2 deficiency impaired cochlear blood-labyrinth barrier via activation of NF-κB signaling pathway

OSBPL2 deficiency impaired cochlear blood-labyrinth barrier via activation of NF-κB signaling pathway

  • Hear Res. 2025 Sep 15:467:109432. doi: 10.1016/j.heares.2025.109432.
Qian Yang 1,  Tianqi Li 2,  Yajie Lu 3,  Tianming Wang 4,  Zhibin Chen 5,  Guangqian Xing 5,  Qinjun Wei 3,  Xin Cao 6,  Jun Yao 7
Affiliations

Affiliations

  • 1 Department of Medical Genetics, School of Basic Medical Science, Nanjing Medical University, Nanjing, China.
  • 2 The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
  • 3 Department of Medical Genetics, School of Basic Medical Science, Nanjing Medical University, Nanjing, China; Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University, Nanjing, China.
  • 4 Central Laboratory, Translational Medicine Research Center, the affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
  • 5 Department of Otolaryngology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • 6 Department of Medical Genetics, School of Basic Medical Science, Nanjing Medical University, Nanjing, China; Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University, Nanjing, China. Electronic address: caoxin@njmu.edu.cn.
  • 7 Department of Medical Genetics, School of Basic Medical Science, Nanjing Medical University, Nanjing, China; Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University, Nanjing, China; Department of Otolaryngology-Head and Neck Surgery, the Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China. Electronic address: joelyao@njmu.edu.cn.
PMID: 40975921 DOI: 10.1016/j.heares.2025.109432
Abstract

OSBPL2 was one of the causal genes responsible for autosomal dominant non-syndromic hearing loss (DFNA) and the pathogenic mechanism of OSBPL2 mutations remain elusive. OSBPL2 was detected to be highly expressed in stria vascularis (SV) of mouse cochleae, in which the blood-labyrinth barrier (BLB) was located as an essential component of cochlear spiral duct. The present study explored a potential pathologic mechanism of OSBPL2 deficiency underlying the structural and functional impact on BLB. Osbpl2-knockout (KO) mice were used to characterize SV permeability, which was measured using FITC-dextran injection. OSBPL2-deficient human umbilical vein endothelial cells (HUVECs) were used to evaluate the endothelial permeability in vitro. Tight junctions (TJs) in SV and HUVECs were characterized using immunofluorescent staining. The results showed that significant SV leakage was detected in cochleae of 10-month-old Osbpl2-KO mice, which was consistent with the increased endothelial permeability in OSBPL2-deficient HUVECs. It was also noted that OSBPL2 deficiency led to TJs disruption and induced inflammation-mediated Apoptosis via the activation of NF-κB signaling. This study revealed the potential pathogenic mechanism of OSBPL2 deficiency in SV lesion, which helped to elucidate the underlying pathogenesis of OSBPL2 mutations in DFNA.

Keywords

Blood-labyrinth barrier; NF-κB signaling; OSBPL2; Stria vascularis; Tight junction.

Figures
Products
Inhibitors & Agonists
Other Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z